Biomolecules (Sep 2023)

Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity

  • Julie Krainer,
  • Michaela Hendling,
  • Sandra Siebenhandl,
  • Sabrina Fuehner,
  • Christoph Kessel,
  • Emely Verweyen,
  • Klemens Vierlinger,
  • Dirk Foell,
  • Silvia Schönthaler,
  • Andreas Weinhäusel

DOI
https://doi.org/10.3390/biom13091392
Journal volume & issue
Vol. 13, no. 9
p. 1392

Abstract

Read online

Systemic juvenile idiopathic arthritis (SJIA) is a severe rheumatic disease in children. It is a subgroup of juvenile idiopathic arthritis (JIA; MIM #604302), which is the most common rheumatic disease in children. The diagnosis of SJIA often comes with a significant delay, and the classification between autoinflammatory and autoimmune disease is still discussed. In this study, we analyzed the immunological responses of patients with SJIA, using human proteome arrays presenting immobilized recombinantly expressed human proteins, to analyze the involvement of autoantibodies in SJIA. Results from group comparisons show several differentially reactive antigens involved in inflammatory processes. Intriguingly, many of the identified antigens had a high reactivity against proteins involved in the NF-κB pathway, and it is also notable that many of the detected DIRAGs are described as dysregulated in rheumatoid arthritis. Our data highlight novel proteins and pathways potentially dysregulated in SJIA and offer a unique approach to unraveling the underlying disease pathogenesis in this chronic arthropathy.

Keywords